Diseases of the Hair and Nails

Medical Clinics of North America

Volumn 93, Issue 6, 2009, Pages 1195-1209

  Harrison, Shannon ^a   Bergfeld, Wilma F ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Anagen effluvium; Hair shaft disorders; Hirsutism; Hypertrichosis; Nail disorders; Telogen effluvium

Indexed keywords

ANABOLIC AGENT; ANDROGEN; ANTICONVULSIVE AGENT; BIOTIN; CYCLOSPORIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FINASTERIDE; HEPARIN; IRON; MINOXIDIL; NANDROLONE; ORAL CONTRACEPTIVE AGENT; RETINOID; SPIRONOLACTONE; TAMOXIFEN; ZINC;

ACROMEGALY; ALOPECIA; ALOPECIA AREATA; ANAGEN EFFLUVIUM; CLUBBED NAIL; CORONARY ARTERY DISEASE; DERMADROME; DIABETES MELLITUS; DISEASE COURSE; GOUT; HAIR DISEASE; HAIR GROWTH; HAIR LOSS; HIRSUTISM; HUMAN; HYPERANDROGENISM; HYPERTHYROIDISM; HYPERTRICHOSIS; HYPOPITUITARISM; HYPOTHYROIDISM; INVERSE NAIL PTERYGIUM; IRON DEFICIENCY; IRON DEFICIENCY ANEMIA; IRON THERAPY; LEUKONYCHIA; MACRONYCHIA; MALABSORPTION; MALNUTRITION; MELANONYCHIA; MENKES SYNDROME; MICRONYCHIA; MUEHRCKE WHITE BAND; NAIL DISEASE; ONYCHOLYSIS; ONYCHORRHEXIS; OVARY POLYCYSTIC DISEASE; OVARY TUMOR; PATHOGENESIS; PINCER NAIL; PRIORITY JOURNAL; RED LUNULA; REVIEW; SCARRING ALOPECIA; SPLINTER HEMORRHAGE; SPOON NAIL; TELOGEN AFFLUVIUM; TELOGEN EFFLUVIUM; TERRY NAIL; THYROID DISEASE; TRICHOTHIODYSTROPHY; TWENTY NAIL DYSTROPHY; VITAMIN SUPPLEMENTATION; YELLOW NAIL SYNDROME; ZINC DEFICIENCY;

HAIR DISEASES; HUMANS; NAIL DISEASES;

EID: 70449732597     PISSN: 00257125     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mcna.2009.08.006     Document Type: Review

References (54)

1. Kligman A.M. Pathologic dynamics of human hair loss. I. Telogen effluvium. Arch Dermatol 83 (1961) 175-198
2. Headington J.E. Telogen effluvium: new concepts and review. Arch Dermatol 129 (1992) 356-363
3. Cotsarelis G., Millar S., and Chan E.F. Embryology and anatomy of the hair follicle. In: Olsen E.A. (Ed). Disorders of hair growth: diagnosis and treatment. 2nd edition (2003), McGraw-Hill Publishing, New York 23-48
4. Paus R., and Cotsarelis G. The biology of hair follicles. N Engl J Med 341 (1999) 491-497
5. Rook A., and Dawber R. Diffuse alopecia: endocrine, metabolic and chemical influences on the follicular cycle. In: Rook A., and Dawber R. (Eds). Diseases of the hair and scalp (1982), Blackwell Scientific Publications, Oxford, UK 115-145
6. Goette D.U., and Odum R.B. Alopecia in crash dieters. JAMA 235 (1976) 2622-2623
7. Bergfeld W.F. Telogen effluvium. In: McMichael A.J., and Hordinsky M.K. (Eds). Hair and scalp diseases: medical, surgical and cosmetic treatments (2008), Informa Healthcare, New York 119-135
8. Apache P.G. Eczematous dermatitis of the scalp. In: Zviak C. (Ed). The science of hair care (1986), Marcel Dekker, New York 513-521
9. Fiedler V.C., and Gray A.C. Diffuse alopecia: telogen hair loss. In: Olsen E.A. (Ed). Disorders of hair growth: diagnosis and treatment. 2nd edition (2003), McGraw-Hill Publishing, USA 303-320
10. Sperling L.C. Hair and systemic disease. Dermatol Clin 19 4 (2001) 711-726
11. Freinkel R., and Freinkel N. Hair growth and alopecia in hypothyroidism. Arch Dermatol 106 3 (1972) 349-352
12. Saito R., Hori Y., and Kuribayashi T. Alopecia in hypothyroidism. In: Kobori T., and Montagna W. (Eds). Biology of diseases of the hair (1976), University of Tokyo Press, Tokyo 279-285
13. Johnson A.A., Latham M.C., and Roe D.A. An evaluation of the use of changes in hair root morphology in the assessment of protein-caloric malnutrition. Am J Clin Nutr 29 (1976) 502-511
14. Rushton D.H., and Ramsey I.D. The importance of adequate serum ferritin levels during oral cyproterone acetate and ethinyl oestradiol treatment of diffuse androgen deoendent alopecia in women. Clin Endocrinol 36 (1992) 421-427
15. Trost L.B., Bergfeld W.F., and Calogeras E. The diagnosis and treatment of iron deficiency and its potential relationship to hair loss. J Am Acad Dermatol 54 (2006) 824-844
16. Vegesna V., O'Kelly J., Uskokovic M., et al. Vitamin D3 analogs stimulate hair growth in nude mice. Endocrinology 143 11 (2002) 4389-4396
17. Whiting D.A. Chronic telogen effluvium. Dermatol Clin 14 (1996) 723-773
18. Whiting D.A. Chronic telogen effluvium: increased scalp hair shedding in middle-aged women. J Am Acad Dermatol 35 6 (1996) 899-906
19. Tosti A., and Pazzaglia M. Drug reactions affecting hair: diagnosis. Dermatol Clin 25 (2007) 223-231
20. Ross E.K., and Shapiro J. Management of hair loss. Dermatol Clin 23 (2005) 227-243
21. Sinclair R., Grossman K.L., and Kvedar J.C. Anagen hair loss. In: Olsen E.A. (Ed). Disorders of hair growth: diagnosis and treatment. 3rd edition (2003), McGraw-Hill Publishing, New York 123-175
22. Madani S., and Shapiro J. Alopecia areata update. J Am Acad Dermatol 42 (2000) 549-566
23. Olsen E.A., Messenger A.G., Shapiro J., et al. Evaluation and treatment of male and female pattern hair loss. J Am Acad Dermatol 52 (2005) 301-311
24. Hamilton J.B. Male hormone stimulation is prerequisite and an incitant in common baldness. Am J Anat 71 (1942) 451-480
25. Futterweit M.D., Dunaif A., Yeh H.-C., et al. The prevalence of hyperandrogenism in 109 consecutive female patients with diffuse alopecia. J Am Acad Dermatol 19 (1988) 831-836
26. Sperling L.C., and Lupton G.P. Histopathology of non-scarring alopecia. J Cutan Pathol 22 2 (1995) 97-114
27. Lesko S.M., Rosenberg L., and Shapiro S. A case-control study of baldness in relation to myocardial infarction in men. JAMA 269 (1993) 9987-10003
28. Carey A.H., Chan K.L., Short F., et al. Evidence for a single gene effect causing polycystic ovaries and male pattern baldness. Clin Endocrinol 38 (1993) 653-658
29. Mofid A., Seyyed Alinaghi S.A., Zandieh S., et al. Hirsutism. Int J Clin Pract 62 3 (2008) 433-443 [Epub 2007 Dec 11]
30. Rosenfield R.L. Clinical practice: hirsutism. N Engl J Med 353 24 (2005) 2578-2588
31. Azziz R., Waggoner W.T., Ochoa T., et al. Idiopathic hirsutism: an uncommon cause of hirsutism in Alabama. Fertil Steril 70 2 (1998) 274-278
32. The Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod 19 1 (2004) 41-47
33. Azziz R., Woods K.S., Reyna R., et al. The prevalence and features of the polycystic ovary syndrome in an unselected population. J Clin Endocrinol Metab 89 6 (2004) 2745-2749
34. Derman R.J. Androgen excess in women. Int J Fertil Menopausal Stud 41 2 (1996) 172-176
35. Martin K.A., Chang R.J., Ehrmann D.A., et al. Evaluation and treatment of hirsutism in premenopausal women: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 93 4 (2008) 1105-1120
36. Practice Committee of the American Society for Reproductive Medicine. The evaluation and treatment of androgen excess. Fertil Steril 86 4 Suppl (2006) S241-S247
37. Olsen E.A. Hypertrichosis. In: Olsen E.A. (Ed). Disorders of hair growth: diagnosis and treatment. 3rd edition (2003), McGraw-Hill Publishing, New York 123-175
38. Whiting D.A. Hair shaft defects. In: Olsen E.A. (Ed). Disorders of hair growth: diagnosis and treatment. 3rd edition (2003), McGraw-Hill Publishing, New York 123-175
39. Ramos-e-Silva M., Azevedo-e-Silva M.C., and Carneiro S.C. Hair, nail and pigment changes in major systemic disease. Clin Dermatol 26 (2008) 296-305
40. Harries M.J., Sinclair R.D., MacDonald-Hull S., et al. Management of primary cicatricial alopecias: options for treatment. Br J Dermatol 159 1 (2008) 1-22
41. Headington J.T. Cicatricial alopecia. Dermatol Clin 14 4 (1996) 773-782
42. Selva D., Chen C.S., James C.L., et al. Discoid lupus erythematosus presenting as madarosis. Am J Ophthalmol 136 3 (2003) 545-546
43. Somani N., and Bergfeld W.F. Classification and histopathologic findings of the cicatricial alopecias. Dermatol Ther 21 4 (2008) 221-237
44. Tosti A., and Piraccini B.M. Biology of the nails and nail disorders. In: Wolff K., Goldsmith L.A., Katz S.I., et al. (Eds). Fitzpatrick's dermatology in general medicine. 7th edition (2008), McGraw Hill Companies Inc, New York 778-794
45. Cribier B., Mena M.L., Rey D., et al. Nail changes in patients infected with human immunodeficiency virus: a prospective controlled study. Arch Dermatol 134 (1998) 1216-1220
46. Sherber N.S., Wigley F.M., and Scher R.K. Autoimmune disorders: nail signs and therapeutic approaches. Dermatol Ther 20 (2007) 17-30
47. Berard R., Scuccimarri R., and Chedeville G. Leukonychia striata in Kawasaki disease: case report. J Pediatr 152 6 (2008) 889
48. Chauchan S., D'Cruz S., Singh R., et al. Mee's lines:case report. Lancet 372 9647 (2008) 1410
49. Zagoni T., Sipos F., Tarjan Z., et al. The half-and-half nail: a new sign of Crohn's disease? Report of four cases. Dis Colon Rectum 49 (2006) 1071-1073
50. Gregariou S., Argyriou G., Larios G., et al. Nail disorders and systemic disease: what the nails tell us. J Fam Pract 57 8 (2008) 509-514
51. Ferris L.K., and English III J.C. The skin in infective endocarditis, sepsis, septic shock, and disseminated intravascular coagulation. In: Wolff K., Goldsmith L.A., Katz S.I., et al. (Eds). Fitzpatrick's dermatology in general medicine. 7th edition (2008), McGraw Hill Companies Inc, New York 1744-1749
52. Prat C., Moreno A., Vinas M., et al. Nail dystrophy in primary systemic amyloidosis [letter]. J Eur Acad Dermatol Venereol 22 1 (2008) 107-109
53. Reich A., Wisnicka B., and Szepietowski J.C. Haemorrhagic nails in pemphigus vulgaris [letter]. Acta Derm Venereol 88 5 (2008) 542
54. Maldonado F., Tazelaar H.D., Wang C.W., et al. Yellow nail syndrome: analysis of 41 patients. Chest 134 2 (2008) 375-381